Clinical Trial Update: Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of dapagliflozin on diabetic endothelial dysfunction in the brachial artery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Disease
• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Diabetes Mellitus, Type 2, Coronary Artery Disease | Phase 4 | Status: COMPLETED